CureGene has dosed the first participant in an Australian Phase I clinical trial of CG-0416, an investigational oral liv...
CStone Pharmaceuticals has received approval from China’s National Medical Products Administration to initiate cli...
China’s biotech and pharmaceutical sector is entering a new phase of global relevance. A surge in out-licensing de...
The Hong Kong Applied Science and Technology Research Institute (ASTRI) and Saint Francis University (SFU), US have sign...
Brii Biosciences has advanced its internally developed mRNA therapeutic cancer vaccine BRII-5395 into clinical evaluatio...
Mankind Pharma, one of India’s leading pharmaceutical companies, has entered into an exclusive in-licensing and ma...
CanSino Biologics has announced that China’s National Medical Products Administration has accepted the New Drug Ap...
Enginprime Medical, a developer of percutaneous ventricular assist device (pVAD) technology, has announced the closing o...
Everest Medicines has announced that China’s National Medical Products Administration has accepted the Biologics L...
Norroy Bioscience, a China-based clinical-stage biotechnology startup focused on innovative targeted radiopharmaceutical...
Shanghai Henlius Biotech has entered into a strategic collaboration with Sandoz, a global leader in generics and bi...
The 2026 CDISC China Interchange has brought clinical research data specialists and industry stakeholders together in Sh...
Asia-Pacific continues to attract investment across pharmaceutical manufacturing, biotechnology, vaccines, advanced ther...
Asia-Pacific is moving from being viewed primarily as a later-stage commercial market to becoming a more important sourc...
The 2026 Global Health Summit opened in Hong Kong with a focus on moving scientific and healthcare innovations from rese...
Ascletis Pharma has initiated two Phase I studies in the United States evaluating investigational once-monthly injectabl...
Innovent Biologics, Inc. and Daiichi Sankyo have entered into an exclusive agreement for the commercialisation of Vanfly...
Long-term diabetes management requires continuous blood glucose monitoring to detect abnormalities early and intervene i...
CSPC Pharmaceutical Group has entered into a contract with AstraZeneca in relation to the establishment of a joint ...
Counterfeit and unauthorised healthcare products remain a persistent risk across Asia, particularly where fragmented dis...
AsymBio, a China-based biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of ...
Suzhou Ribo Life Science and its subsidiary Ribocure Pharmaceuticals have reported positive Phase IIa results for vortos...
Shanghai Ark Biopharmaceutical, or ArkBio, has completed dosing across all healthy-volunteer cohorts in an Australian Ph...
Harbour BioMed and Kelun-Biotech have received approval from China’s National Medical Products Administration to b...
Antengene has received a $60 million upfront payment from UCB under a worldwide exclusive licensing agreement for ATG-20...
